FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new derivatives of 4-phenylpyrimidine and their pharmaceutically acceptable acid-additive salts that elicit properties of antagonist of neurokinin (NK-1) receptors. These compounds can be used in treatment of diseases mediated by NK-1 receptors, for example, headache, Alzheimer's diseases, cerebrospinal sclerosis, cardiovascular disorders, edema, chronic inflammatory diseases and so on. Proposed compounds correspond to the general formula (I):
wherein R1 means hydrogen or halogen atom; R2 means hydrogen, halogen atom, lower alkyl or lower alkoxy-group; R1 and R2 in common with two atoms of carbon cycle can mean the group -CH=CH-CH=CH-; R3 means halogen atom, trifluoromethyl, lower alkyl or lower alkoxy-group; R4/R4' each means independently of one another hydrogen atom or lower alkyl; R5 means lower alkyl, lower alkoxy-group, amino-group, phenyl, hydroxy-(lower)-alkyl, cyano-(lower)-alkyl, carbamoyl-(lower)-alkyl, pyridyl, pyrimidyl, -(CH2)n-piperazinyl substituted optionally with one or two lower alkyl groups or hydroxy-(lower)-alkyl, -(CH2)n-morpholinyl, -(CH2)n-piperidinyl, -(CH2)n+1-imidazolyl, lower alkylsulfanyl, lower alkylsulfonyl, benzylamino-group, -NH-(CH2)n+1-N(R4'')2, -(CH2)n+1-N(R4'')2, -O-(CH2)n+1-morpholinyl, -O-(CH2)n+1-piperidinyl or -O-(CH2)n+1-N(R4'')2 wherein 4'' means hydrogen atom or lower alkyl; n = 0-2; X means -C(O)N(R4'')- or -N(R4'')C(O)-. Also, invention relates to a pharmaceutical composition.
EFFECT: valuable medicinal properties of compounds.
11 cl, 6 sch, 121 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 5-PHENYLPYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2244710C2 |
DERIVATIVES OF PYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2284997C2 |
DERIVATIVES OF DIPHENYL AND MEDICINAL AGENT | 2000 |
|
RU2238266C2 |
DERIVATIVES OF PYRIDINE AND PYRIMIDINE, METHODS FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION AND USING | 2003 |
|
RU2293731C2 |
MODULATORS OF ADENOSINE RECEPTORS | 2001 |
|
RU2277911C2 |
PYRIMIDINE HYDRAZIDE COMPOUNDS AS PGDS INHIBITORS | 2008 |
|
RU2464262C2 |
PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | 2006 |
|
RU2420519C2 |
ERK2 HETEROCYCLIC INHIBITORS AND THEIR USING | 2002 |
|
RU2300377C2 |
SUBSTITUTED PYRIMIDINES AND USE THEREOF AS JNK MODULATORS | 2007 |
|
RU2493155C2 |
APPLICATION OF RECEPTOR NK-1 ANTAGONISTS FOR TREATING CRANIOCEREBRAL AND SPINAL TRAUMAS OR NERVOUS TISSUE LESION | 2002 |
|
RU2304435C2 |
Authors
Dates
2004-12-27—Published
2000-05-24—Filed